Lee I. Garner

发表

CD6 monoclonal antibodies differ in epitope, kinetics and mechanism of action

Marion H. Brown, Lee I. Garner, A. Hartland, 2018, Immunology.

Expression, purification, and refolding of the myeloid inhibitory receptor leukocyte immunoglobulin-like receptor-5 for structural and ligand identification studies.

B. Willcox, Lee I. Garner, M. Salim, 2006, Protein expression and purification.

Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonist

A. B. Hassan, F. Buffa, Rory Maclean, 2016, Proceedings of the National Academy of Sciences.

Structures of CD6 and Its Ligand CD166 Give Insight into Their Interaction

C. Robinson, Steven Johnson, S. Lea, 2015, Structure.

CD6 mAbs differ in epitope, kinetics and mechanism of action

Marion H. Brown, Lee I. Garner, A. Hartland, 2018 .

Fine Specificity and Molecular Competition in SLAM Family Receptor Signalling

Marion H. Brown, T. Wilson, C. Metcalfe, 2014, PloS one.

Structural and molecular studies of group II leukocyte immunoglobulin-like receptors

Lee I. Garner, Lee Garner, 2011 .

Crystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k)

G. Gao, J. Qi, Jinghua Yan, 2011, The Journal of Biological Chemistry.

Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex molecules.

P. Moss, N. Khan, A. Rickinson, 2005, The Journal of infectious diseases.

An unbiased characterization of the HLA-E and CD94/NKG2x peptide repertoire reveals peptide ligands that skew NK cell activation

A. McMichael, M. Birnbaum, Brooke D. Huisman, 2022, bioRxiv.

A polymorphism in a phosphotyrosine signalling motif of CD229 (Ly9, SLAMF3) alters SH2 domain binding and T‐cell activation

Marion H. Brown, T. Wilson, Lee I. Garner, 2015, Immunology.